GSS - A Sleeping Genomic Bull?Genetic Signatures Ltd. is a research company engaging in the identification & commercialization of individual genetic signatures purposed for diagnosing infectious diseases.
A more specific focus lately has been on clinical Gastro-intestinal parasite testing kits named 'EasyScreen GI Parasite Kit', which received FDA 510(k) clearance in May/June 2024.
US uptake has been slower than expected, however group revenue figures are showing promising signs with FY25 revenue reaching $15.9m, well beyond FY24 revenue of $9.77m.
The market will be watching closely to see if revenue can continue to scale, and whether meaningful margin can be established, noting FY25 income although up on FY24, is still below FY23's result.
Our Team has identified a point of potential interest & volatility in this code ASX:GSS .
If price can hold above $0.245 ... Significant Bullish potential may be unlocked.
If however price falls below $0.245 ... Significant Bearish risk may come into play.
We're inspired to bring you the latest developments across worldwide markets, helping you look in the right place, at the right time.
Thank you for reading! Stay tuned for further updates, and we look forward to being of service along your trading & investing journey...
Disclaimer: Please note all information contained within this post and all other Bullfinder-official Tradingview content is strictly for informational purposes only and is not intended to be investment advice. Please DYOR & Consult your licensed financial advisors before acting on any information contained within this post, or any other Bullfinder-official TV content.
Genetic Signatures Ltd.
No trades
No trades
In-depth trading ideas
$GSS Quarterly results support the sp. Or is it the other way?ATH close tonight. Seemed to be itchy to break $2 before the close. Looks like Q4 revenue should be a minimum of $5M which is over 200% increase on any other quarter. A growth stock if ever I saw one. See if it follows through tomorrow and then onto who knows where.
$GSS - Genetics Signature is it time to buy now?On the weekly note,
We have a weak bullish TK cross, prices have closed above the cloud which is a good sign that the current support at $0.38 holds. Currently it is a long term hold if you are looking into buying $GSS.
Short term outlook: RSI is hovering close to oversold conditions, Chaikin Money Flow is dropping and that means the buying power is weakening. This is in line with the decreasing volume.
For entries, see below for daily chart.

















